For many people, the word “remission” is most often associated with cancer. But in recent years, it has become the clinical standard for describing something increasingly important in metabolic health:
When type 2 diabetes goes into reverse.
In 2021, a joint consensus by the American Diabetes Association, Diabetes UK, and European Association for the Study of Diabetes established a shared definition: Diabetes remission is defined as maintaining an HbA1c below 48 mmol/mol (6.5%) for at least three months, without glucose-lowering medication.
Remission does not mean diabetes has been permanently cured. The underlying tendency toward insulin resistance may still exist. However, for many individuals, remission means:
-
Living without the need for medication
-
Avoiding medication-related side effects
-
Reducing the risk of long-term complications
Including:
-
Nerve damage (neuropathy)
-
Kidney disease
-
Cardiovascular disease
In that sense, remission represents a significant shift in both quality of life and long-term outcomes.
Research consistently shows that higher success rates are seen in individuals who:
-
Have a shorter duration of diabetes
-
Have lower baseline HbA1c levels
-
Are not yet dependent on insulin
This highlights a key message: Early action matters.
The landmark DiRECT trial demonstrated that:
-
57% of participants achieved remission at 1 year
-
This decreased to ~36% at 2 years
The drop was not due to failure of the approach but due to the difficulty of maintaining weight loss without structured support. Participants who sustained their weight loss had the highest likelihood of maintaining remission.
Type 2 diabetes is strongly linked to:
-
Excess fat accumulation in the liver and pancreas
-
Insulin resistance
Research led by Roy Taylor has shown that reducing this excess fat can restore metabolic function in some individuals.
This is why remission is more likely when the approach focuses on:
-
Meaningful, sustained weight loss
-
Dietary strategies that reduce visceral fat
-
Improvements in insulin sensitivity
Rather than simply managing blood glucose levels alone.
One of the most important insights from research is this that sustained change requires:
-
Guidance
-
Accountability
-
Personalisation
-
Continuity of care
Without these, even effective strategies can be difficult to maintain.
At Remisi, our programme is designed around the goal of remission.
We focus on:
-
Chrononutrition (aligning eating patterns with circadian rhythms)
-
Gut health optimisation
-
Stress reduction
-
Personalised movement strategies
All delivered through an interdisciplinary, lifestyle medicine-based approach.
Type 2 diabetes does not have to be viewed as a lifelong, progressively worsening condition. With the right approach, remission is achievable.
References
-
ADA / Diabetes UK / EASD Consensus Report (2021)
-
Lean MEJ, et al. (2018, 2019). The Lancet (DiRECT trial)
-
Taylor R. (Newcastle University research on type 2 diabetes remission)
